Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats

Psychopharmacology

Volumn 140, Issue 1, 1998, Pages 75-80

  Swerdlow, Neal R ^a   Bakshi, Vaishali ^a   Waikar, Manoj ^a   Taaid, Navid ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotics; Chlorpromazine; Clozapine; Haloperidol; Ketamine; Prepulse inhibition; Schizophrenia; Seroquel

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; QUETIAPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; CLOZAPINE; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; KETAMINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STARTLE REACTION;

EID: 0031759855     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050741     Document Type: Article

References (21)

1. Bakshi VP, Geyer MA (1995) Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology 122:198-201
2. Bakshi VP, Geyer MA (1997) Reversal of phencyclidine-induced deficits in prepulse inhibition by prazosin, an alpha-1 adrenergic antagonist. J Pharmacol Exp Ther 283:666-674
3. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
4. Bakshi VP, Waikar M, Swerdlow NR, Geyer MA (1997) Ketamine disrupts preopulse inhibition. Reversal by clozapine and Seroquel. Biol Psychiatry 41:43S
5. Bolino F, Di Michele V, Di Cicco L, Manna V, Daneluzzo E, Cassachia M. Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia. Biol Psychiatry 36:670-679
6. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali E (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343
7. Braff DL, Grillon C, Geyer M (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
8. Christensen AV, Arnt J, Svendsen O (1984) Animal models for neuroleptic-induced neurological dysfunction. In: Usdin E, Carlsson A, Dahlstrom A, Engel J (eds) Catecholamines neuropharmacology and central nervous system therapeutic aspects. Liss, New York, pp 99-109
9. Geyer MA, Swerdlow NR (1998) The startle response and its use in preclinical measures of sensorimotor gating. In: Crawley JN, Skolnick P (eds) Current protocols in neuroscience, Chapter 8. Wiley, New York (in press)
10. Graham F (1975) The more or less startling effects of weak prestimuli. Psychophysiology 12:238-248
11. Karper LP, Grillon C, Charney DS, Krystal JH (1994) The effect of ketamine on pre-pulse inhibition and attention. Proc Am Coll Neuropsychopharmacol 124
12. Keith VA, Mansbach RS, Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30:557-566
13. Mansbach RS, Geyer MA (1989) Effects of phencyelidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308
14. Mansbach RS, Geyer MA (1991) Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine. Psychopharmacology 105:162-168
15. Morton N, Ellis C, Gray NS, Toone BK, Leigh PN, Chaudhuri KR (1995) The effects of apomorphine and L-dopa challenge on prepulse inhibition in patients with Parkinson's disease. Schizophr Res 15:181
16. Richelson E (1984) Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. J Clin Psychiatry 45:331-336
17. Schotte A, Janssen PF, Megens AA, Leysen JE (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 631:191-202
18. Swerdlow NR, Geyer MA (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44:741-744
19. Swerdlow NR, Geyer M, Braff D, Koob GF (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biol Psychiatry 21:23-33
20. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients. Arch Gen Psychiatry 51:139-154
21. Swerdlow NR, Bakshi V, Geyer MA (1996) Seroquel restores sensorimotor gating in phencyclidine (PCP)-treated rats. J Pharmacol Exp Ther 279:1290-1299